The global breast biopsy market is experiencing strong growth due to the increasing prevalence of breast cancer, rising awareness regarding early cancer detection, advancements in diagnostic imaging technologies, and growing adoption of minimally invasive biopsy procedures. The global breast biopsy market size was valued at USD 2.83 billion in 2025 and is projected to grow from USD 3.13 billion in 2026 to USD 7.11 billion by 2034, registering a CAGR of 10.8% during the forecast period (2026–2034).

Breast biopsy is a medical procedure used to remove a sample of suspicious breast tissue for laboratory examination to determine the presence of cancerous or non-cancerous cells. Modern breast biopsy techniques, including image-guided and minimally invasive procedures, provide accurate diagnoses while reducing patient discomfort and recovery time.

Market Drivers

Rising Incidence of Breast Cancer

The growing global burden of breast cancer is significantly increasing demand for accurate and early diagnostic procedures, including breast biopsies.

Growing Awareness of Early Detection

Public health initiatives, awareness campaigns, and routine screening programs are encouraging women to undergo regular breast examinations and diagnostic testing.

Advancements in Imaging Technologies

Technological improvements in mammography, ultrasound, MRI, and digital breast tomosynthesis are enhancing biopsy accuracy and supporting market growth.

Increasing Preference for Minimally Invasive Procedures

Patients and healthcare providers are increasingly adopting minimally invasive biopsy techniques due to reduced pain, lower complication rates, and faster recovery.

Expansion of Healthcare Infrastructure

Growing investments in diagnostic centers, hospitals, and cancer care facilities are improving access to breast biopsy procedures worldwide.

For Detailed Insights, Visit:

https://straitsresearch.com/report/breast-biopsy-market

Market Challenges

High Diagnostic Procedure Costs

Advanced imaging-guided biopsy procedures and specialized equipment can increase overall healthcare expenses.

Limited Access in Developing Regions

Many low- and middle-income countries continue to face challenges related to healthcare infrastructure and diagnostic accessibility.

Risk of Diagnostic Errors

Although highly accurate, biopsy procedures may occasionally result in false-negative or inconclusive findings, requiring additional testing.

Shortage of Skilled Professionals

The effective performance and interpretation of biopsy procedures require experienced radiologists, pathologists, and healthcare specialists.

Market Segmentation

The breast biopsy market is segmented based on procedure type, guidance technique, end user, and region.

By Procedure Type

The market is categorized into:

• Core Needle Biopsy

• Fine Needle Aspiration Biopsy

• Vacuum-Assisted Breast Biopsy

• Surgical Biopsy

• Others

Core needle biopsy accounts for a significant market share due to its high accuracy, minimally invasive nature, and widespread clinical use.

By Guidance Technique

The market includes:

• Ultrasound-Guided Biopsy

• Stereotactic-Guided Biopsy

• MRI-Guided Biopsy

• CT-Guided Biopsy

Ultrasound-guided biopsy dominates the market owing to its cost-effectiveness, real-time imaging capabilities, and broad availability.

By End User

The market is segmented into:

• Hospitals

• Diagnostic Imaging Centers

• Specialty Clinics

• Ambulatory Surgical Centers

Hospitals represent the largest end-user segment due to the availability of advanced diagnostic equipment and specialized healthcare professionals.

By Region

The market is analyzed across:

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

Regional Insights

North America

North America dominates the breast biopsy market due to advanced healthcare infrastructure, widespread breast cancer screening programs, high healthcare spending, and the presence of leading medical device manufacturers.

Europe

Europe holds a substantial market share supported by increasing awareness initiatives, government-funded screening programs, and technological advancements in diagnostic imaging.

Asia-Pacific

Asia-Pacific is expected to witness the fastest growth due to rising breast cancer incidence, improving healthcare infrastructure, growing healthcare expenditures, and increasing awareness across China, India, Japan, and South Korea.

Latin America

Latin America is experiencing steady growth due to expanding access to cancer diagnostics and increasing investments in healthcare services.

Middle East & Africa

The region is witnessing gradual market expansion driven by healthcare modernization initiatives and growing cancer awareness campaigns.

Technology Trends and Market Opportunities

The breast biopsy market is evolving through innovations in robotic-assisted biopsy systems, artificial intelligence-powered imaging analysis, digital pathology, 3D breast imaging technologies, and advanced vacuum-assisted biopsy devices. Healthcare providers are increasingly focusing on improving diagnostic precision, reducing procedure times, and enhancing patient outcomes.

Growing investments in personalized medicine, precision oncology, cancer screening programs, and AI-enabled diagnostic platforms are creating substantial opportunities for market participants. Furthermore, increasing adoption of minimally invasive diagnostic procedures is expected to support long-term market growth.

Key Players Analysis

The breast biopsy market is highly competitive, with major companies focusing on product innovation, strategic partnerships, regulatory approvals, and advanced diagnostic technologies.

Major companies operating in the market include:

• Hologic, Inc.

• BD (Becton, Dickinson and Company)

• Siemens Healthineers AG

• GE HealthCare Technologies Inc.

• FUJIFILM Holdings Corporation

• Argon Medical Devices, Inc.

• Cook Medical LLC

• Mammotome

• Danaher Corporation

• Merit Medical Systems, Inc.

These companies continue to invest in advanced biopsy technologies, AI-powered imaging solutions, minimally invasive diagnostic devices, and precision oncology applications to strengthen their positions in the global breast biopsy market.

Related Report

Breast Imaging Market

https://straitsresearch.com/report/breast-imaging-market

About Us

Straits Research is a leading market research and intelligence organization specializing in analytics, advisory services, and comprehensive market research reports across multiple industries.

Contact Us

Email: sales@straitsresearch.com

U.S. Tel: +1 646 905 0080

U.K. Tel: +44 203 695 0070